|
May 27
|
AstraZeneca (LSE:AZN) Gains EU Recommendation For Imfinzi in Bladder Cancer Treatment
|
|
May 27
|
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer
|
|
May 26
|
Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
|
|
May 23
|
European Equities Close Sharply Lower in Friday Trading; German Q1 GDP Expands 0.4% Sequentially
|
|
May 23
|
Aptar Digital to use AstraZeneca’s AI algorithms for CKD detection
|
|
May 21
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 21
|
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust
|
|
May 21
|
AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?
|
|
May 21
|
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer
|
|
May 21
|
3 Promising Growth Stocks You Can Buy for Less Than $100
|
|
Apr 25
|
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS
|
|
Apr 25
|
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
|
Apr 24
|
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
|
|
Apr 24
|
Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key Metrics
|
|
Apr 24
|
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
|
|
Apr 24
|
Can Biogen Keep the Beat Streak Alive This Earnings Season?
|
|
Apr 23
|
AstraZeneca pushes EU to spend more on drugs amid Trump tariffs threat
|
|
Apr 23
|
Drug firm bosses call for price increases in Europe amid tariff uncertainty
|
|
Apr 23
|
Why Tempus AI Stock Is Skyrocketing Today
|
|
Apr 22
|
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
|